MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
about
The Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesismiRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancersA novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activationMicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.Noncoding RNAs in endocrine malignancyMolecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog.High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinomaMolecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathwayMolecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate CytologyNew global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cellsmiRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease.Up-regulation of Serum MiR-130b-3p Level is Associated with Renal Damage in Early Lupus Nephritis.Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer.Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas.Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity.RETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaTargeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.MicroRNA expression profiles in differentiated thyroid cancer, a reviewMicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma.Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery CentersExpression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.MiRNAs which target CD3 subunits could be potential biomarkers for cancers.MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].
P2860
Q26800055-CA4F58EC-B9BD-42D7-8386-54F43C5367B1Q28078451-9C733E87-9725-445F-89CB-2C2B2FBC6BF7Q28480605-EA47970C-62EE-4A21-B733-FD31BAD280F3Q33568629-402AABEA-1CA7-4D0C-BE04-E1FA0D93FB78Q33577889-502B5F26-1E29-47C6-9357-BB1202DFDFA9Q33624558-1AC1D534-D53C-43C3-BBAB-C7DA20220F85Q33750895-14897C10-4C83-4F1D-9788-48DC67D388EEQ33843200-F420DE3A-E649-44BC-8A80-8E05874C3847Q34079131-BF605CA8-E3D4-4D7A-AD19-F4CD6B5E8061Q34221160-E550D066-9DA5-4683-9674-D45000B39A7DQ34252329-8C558135-06BC-4B40-9244-7DF7BDF80385Q34312916-92FF9602-9465-45B8-8FC9-5473E342001AQ34533796-DC0C989F-2B9F-49E3-81A6-668980F1C219Q34685429-AAF75A2D-6C97-43A7-8E43-889DC8967234Q34989346-D10D29A2-E6EF-4C3F-889C-1C550744A409Q35052873-380A577B-059B-478D-9227-EAE4A1CCC394Q35097232-EB30AAF8-6ADF-4744-A9FF-883AB744C01EQ35813259-3AB2C254-9084-44B3-B1FB-14BA9BAB5EB4Q35815485-B16079FA-3564-4A9B-B95D-A4A79D7F9F30Q35925504-314B5A01-99E6-461C-A8AC-0D48D7E67F28Q35942714-BC5B29FE-0270-4ACA-9D07-8FBFDAECDF87Q36002595-93F540E9-6124-40C3-B333-595977ABA186Q36013599-B3ADBE26-A441-4FC1-9D55-A09D70EE7651Q36015168-CDCE210A-F110-4872-8748-6EE20B1373EEQ36061807-CBA22AE8-754B-4DD9-8E83-D373C45C0460Q36131618-06D9E201-ABAD-4D23-985A-09369D263171Q36172671-110D7D27-AB11-41E7-86C9-DD7A0AF9FBD7Q36182811-8A3B2BBA-FEA4-4706-B11D-B6C3ABBF3E35Q36255905-760D800F-2371-433B-8D5F-B0E33DF853ADQ36449793-5324C2AE-211B-4E53-AA17-AE824F807855Q36508828-834EFD23-8720-4D17-B3D0-952D5FB2CE42Q36738590-ACCE3C22-9354-45AE-BCD9-DA5A2E7A1073Q36786213-99D3DCAD-D362-49C0-8EB1-C80B15DA6CB5Q36804803-DF1119FA-1AED-4776-A074-89B3082BAF3AQ36882561-BEF74B95-DED9-409B-9A29-54FEB079502FQ36993572-DD577D1F-965B-4EEF-A700-22B6EAF17612Q37032712-5BBE34D5-1825-4911-904E-53DB1F04EE11Q37293498-12FBFC5A-BBF5-40E5-B9A5-C3129E352492Q37297742-EBDB00A8-6FA5-4BE9-94C0-C4611FEC0B14Q37549278-D4623A80-779C-4A29-B25F-A88E00114145
P2860
MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@ast
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@en
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@nl
type
label
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@ast
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@en
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@nl
prefLabel
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@ast
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@en
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@nl
P2093
P2860
P1476
MicroRNA signature distinguish ...... f papillary thyroid carcinoma.
@en
P2093
Lindsey Kelly
Linwah Yip
Marina N Nikiforova
Michaele J Armstrong
Sally E Carty
Yongli Shuai
Yuri E Nikiforov
P2860
P2888
P304
P356
10.1245/S10434-011-1733-0
P577
2011-05-03T00:00:00Z
P6179
1043784038